G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $236,000 | -55.2% | 20,495 | -5.8% | 0.00% | -100.0% |
| Q2 2020 | $527,000 | +34.8% | 21,754 | -38.7% | 0.00% | 0.0% |
| Q1 2020 | $391,000 | -71.2% | 35,494 | -30.8% | 0.00% | 0.0% |
| Q4 2019 | $1,356,000 | -19.5% | 51,303 | -24.6% | 0.00% | -50.0% |
| Q3 2019 | $1,684,000 | +9.3% | 68,013 | +35.3% | 0.00% | +100.0% |
| Q2 2019 | $1,541,000 | +162.1% | 50,272 | +42.0% | 0.00% | 0.0% |
| Q1 2019 | $588,000 | +130.6% | 35,406 | +165.8% | 0.00% | – |
| Q4 2018 | $255,000 | – | 13,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |